Creative Planning boosted its stake in shares of Arcosa, Inc. (NYSE:ACA – Free Report) by 38.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,218 shares of the company’s stock after buying an additional 3,672 shares during the quarter. Creative Planning’s holdings in Arcosa were worth $1,253,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the stock. Xponance Inc. boosted its stake in Arcosa by 4.4% during the second quarter. Xponance Inc. now owns 3,073 shares of the company’s stock worth $256,000 after buying an additional 130 shares during the period. Sei Investments Co. lifted its position in shares of Arcosa by 1.1% during the second quarter. Sei Investments Co. now owns 13,495 shares of the company’s stock worth $1,126,000 after purchasing an additional 146 shares in the last quarter. Arizona State Retirement System lifted its position in shares of Arcosa by 1.5% during the second quarter. Arizona State Retirement System now owns 13,595 shares of the company’s stock worth $1,134,000 after purchasing an additional 195 shares in the last quarter. Evergreen Capital Management LLC lifted its position in shares of Arcosa by 5.5% during the second quarter. Evergreen Capital Management LLC now owns 4,444 shares of the company’s stock worth $371,000 after purchasing an additional 233 shares in the last quarter. Finally, Covestor Ltd lifted its position in shares of Arcosa by 38.8% during the first quarter. Covestor Ltd now owns 888 shares of the company’s stock worth $77,000 after purchasing an additional 248 shares in the last quarter. Hedge funds and other institutional investors own 90.66% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on ACA shares. Oppenheimer increased their price target on shares of Arcosa from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Monday, August 19th. Barclays started coverage on shares of Arcosa in a research report on Tuesday. They set an “overweight” rating and a $106.00 price target on the stock. Finally, Stephens raised shares of Arcosa from an “equal weight” rating to an “overweight” rating and set a $96.00 price target on the stock in a research report on Wednesday, August 7th.
Insider Buying and Selling
In related news, CEO Antonio Carrillo acquired 12,125 shares of Arcosa stock in a transaction dated Thursday, August 8th. The stock was acquired at an average price of $82.05 per share, for a total transaction of $994,856.25. Following the transaction, the chief executive officer now owns 406,275 shares of the company’s stock, valued at $33,334,863.75. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Antonio Carrillo acquired 12,125 shares of Arcosa stock in a transaction dated Thursday, August 8th. The stock was acquired at an average price of $82.05 per share, for a total transaction of $994,856.25. Following the transaction, the chief executive officer now owns 406,275 shares of the company’s stock, valued at $33,334,863.75. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven J. Demetriou acquired 6,000 shares of Arcosa stock in a transaction dated Thursday, September 12th. The shares were bought at an average price of $87.70 per share, with a total value of $526,200.00. Following the transaction, the director now directly owns 9,943 shares in the company, valued at approximately $872,001.10. The trade was a 100.00 % increase in their position. The disclosure for this purchase can be found here. 1.30% of the stock is owned by insiders.
Arcosa Stock Up 0.9 %
Shares of Arcosa stock opened at $95.16 on Thursday. Arcosa, Inc. has a 52-week low of $61.98 and a 52-week high of $97.65. The company has a 50 day moving average of $91.52 and a 200 day moving average of $86.81. The company has a quick ratio of 1.36, a current ratio of 2.31 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $4.62 billion, a P/E ratio of 32.59 and a beta of 0.71.
Arcosa (NYSE:ACA – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.08. Arcosa had a net margin of 6.05% and a return on equity of 6.35%. The company had revenue of $664.70 million during the quarter, compared to the consensus estimate of $661.54 million. During the same quarter in the previous year, the firm earned $0.76 earnings per share. The firm’s quarterly revenue was up 13.7% on a year-over-year basis. As a group, research analysts forecast that Arcosa, Inc. will post 3.39 EPS for the current fiscal year.
Arcosa Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be paid a $0.05 dividend. The ex-dividend date is Tuesday, October 15th. This represents a $0.20 dividend on an annualized basis and a yield of 0.21%. Arcosa’s dividend payout ratio is currently 6.85%.
About Arcosa
Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.
See Also
- Five stocks we like better than Arcosa
- How to invest in marijuana stocks in 7 stepsĀ
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Breakout Stocks: What They Are and How to Identify Them
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- The Risks of Owning Bonds
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Want to see what other hedge funds are holding ACA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arcosa, Inc. (NYSE:ACA – Free Report).
Receive News & Ratings for Arcosa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcosa and related companies with MarketBeat.com's FREE daily email newsletter.